Hatem brings over 30 years of international experience in pharmaceutical general management, business development, and M&A across the MENA region. His career spans senior P&L leadership at Novartis Consumer Health — where he doubled regional revenue over five years as Operating Unit Head for the Middle East, Iran, and Pakistan — through to Galderma, where he achieved 35%+ year-on-year OTC growth across 60 new product introductions, and Nestlé Health Science, where he led full business operations across the Coastal Arabia cluster.

He has led end-to-end M&A due diligence on transactions exceeding $100 million, acquired a local consumer brand generating over $10 million within three years, and founded MODAWA LLC — the first Total Parenteral Nutrition compounding facility outside a hospital in the Middle East, achieving swift regulatory approval.

Dr. Othman Al-Mutlaq brings over 25 years of senior pharmaceutical leadership across regulatory affairs, corporate affairs, and government relations — spanning Novartis and GlaxoSmithKline, a founding regulatory role at Tabuk Pharmaceutical Industries, and a formative period as Technical Registration Committee Secretary at Saudi Arabia's Ministry of Health, where he served on the MoH Legislation Committee across multiple pharmaceutical guidelines.

At Novartis, he spent 23 years growing from Scientific Regulatory Manager to Head of Corporate Affairs for MEA — building the regional regulatory infrastructure across 42 markets, authoring three major national healthcare policies, architecting a landmark strategic investment agreement between Novartis Global and the Saudi Government, and leading the development of pharmaceutical marketing codes and regional HQ frameworks subsequently adopted at government decree level.